Edition:
India

MEI Pharma Inc (MEIP.OQ)

MEIP.OQ on NASDAQ Stock Exchange Capital Market

2.15USD
11:21pm IST
Change (% chg)

$0.02 (+0.94%)
Prev Close
$2.13
Open
$2.13
Day's High
$2.16
Day's Low
$2.13
Volume
6,974
Avg. Vol
37,359
52-wk High
$3.26
52-wk Low
$1.45

Select another date:

Thu, Jan 11 2018

BRIEF-Helsinn Group and MEI Pharma's Pracinostat receives orphan drug designation from European Medicines Agency

* HELSINN GROUP AND MEI PHARMA ANNOUNCE THAT PRACINOSTAT HAS RECEIVED ORPHAN DRUG DESIGNATION FROM THE EUROPEAN MEDICINES AGENCY FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) Source text for Eikon: Further company coverage:

BRIEF-MEI Pharma Announces FDA Clearance Of Investigational New Drug Application For CDK Inhibitor Voruciclib

* MEI PHARMA ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR CDK INHIBITOR VORUCICLIB

BRIEF-Mei Pharma enters into at-market equity offering sales agreement

* On Nov. 8, 2017, co entered into at--market equity offering sales agreement with Stifel, Nicolaus & Company, Incorporated, as sales agent​

BRIEF-Mei Pharma announces exclusive license agreement with Presage Biosciences for voruciclib

* Mei Pharma announces exclusive license agreement with Presage Biosciences for voruciclib, an oral, selective cdk inhibitor

BRIEF-Helsinn group and Mei Pharma announce first patient dosed in myeloid leukemia study

* Helsinn group and Mei Pharma announce first patient dosed in pivotal phase 3 study of pracinostat and azacitidine in acute myeloid leukemia Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Select another date: